In an interaction with Lakshay Kataria, CFO, J B Chemicals & Pharmaceuticals Ltd
In an interaction with Lakshay Kataria, CFO, J B Chemicals & Pharmaceuticals Ltd

In an interaction with Lakshay Kataria, CFO, J B Chemicals & Pharmaceuticals Ltd

In India, our big brands showcased sustained growth and got bigger supported by our new go-to-market model, and whilst doing so we also upped our focus on the new product; emphasizes Lakshay Kataria, Chief Financial Officer, J B Chemicals & Pharmaceuticals Ltd

Sayali Kotwal Article rating: 4.3

In India, our big brands showcased sustained growth and got bigger supported by our new go-to-market model,and whilst doing so we also upped our focus on the new product; emphasizes Lakshay Kataria, Chief Financial Officer, J B Chemicals & Pharmaceuticals Ltd. 

Top-performing pharma stocks in July 2022
Top-performing pharma stocks in July 2022

Top-performing pharma stocks in July 2022

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  

Sayali Kotwal Article rating: 3.7

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  The domestic market is anticipated to increase three times in the next ten years, according to the Indian Economic Survey 2021.

 

DSIJ MINDSHARE

Mkt Commentary13-Nov, 2024

Mindshare13-Nov, 2024

Mindshare13-Nov, 2024

Mindshare13-Nov, 2024

Mindshare13-Nov, 2024

Knowledge

General13-Nov, 2024

General10-Nov, 2024

MF28-Oct, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR